[1] | Shang H,Chen H,Zhao D M,et al.Synthesis and Biological Evaluation of 4α/4β-Imidazolyl Podophyllotoxin Analogues as Antitumor Agents[J]. Arch Pharm Chem Life Sci,2012,345(1):43-48. | [2] | SHANG Hai,PAN Li,YANG Shu,et al.Progress in The Study of Tubulin Inhibitors[J]. Acta Pharm Sin,2010,45(9):1078-1088(in Chinese). 尚海,潘莉,杨澍,等. 微管蛋白抑制剂的研究进展[J]. 药学学报,2010,45(9):1078-1088. | [3] | LI Yaowu,ZHOU Youjun,ZHU Ju,et al.Study on The Binding Modes of The Colchicine-Site Inhibitors and Construction of Their Structural Model[J]. Acta Chim Sin,2008,66(14):1735-1739(in Chinese). 李耀武,周有骏,朱驹,等. 作用于秋水仙碱位点的微管蛋白抑制剂的结合模式研究和结构构型的构建[J]. 化学学报,2008,66(14):1735-1739. | [4] | REN Xiaolan,WANG Xin,LI Zhiyu,et al.Research Progresses of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors[J]. Chinese New Drugs J,2005,14(7):821-826(in Chinese). 任晓岚,汪鑫,李志裕,等. 表皮生长因子受体(EGFR)酪氨酸激酶抑制剂的研究进展[J]. 中国新药杂志,2005,14(7):821-826. | [5] | ZHANG Xiaotong. Targeted Therapy of Lung Cancer[J]. Chinese J Lung Cancer,2004,7(3):256-259(in Chinese). 张晓彤. 肺癌的靶向治疗[J]. 中国肺癌杂志,2004,7(3):256-259. | [6] | Laskin J J,Sandler A B. Epidermal Growth Factor Receptor A Promising Target in Solid Tumours[J]. Cancer Treat Rev,2004,30(1):1-17. | [7] | Vlahovic G,Crawford J. Activation of Tyrosine Kinases in Cancer[J]. Oncologist,2003,8(6):531-538. | [8] | Ravaud A,Hawkins R,Gardner J P,et al.Lapatinib Versus Hormone Therapy in Patients with Advanced Renal Cell Carcinoma:A Randomized Phase III Clinical Trial[J]. J Clin Oncol,2008,26(14):2285-2291. | [9] | Carter M C,Cockerill G S,Guntrip S B,et al. Bicyclic Heteroaromatic Compounds [Quinazolinamines,Pyridopyri-midines,and Analogs] Useful as Protein Tyrosine Kinase Inhibitors:WO,9935146A1.[P],1999-07-15. | [10] | Sato T,Watanabe H,Tsuganezawa K,et al.Identification of Novel Drug-resistant EGFR Mutant Inhibitors by I-nsilico Screening Using Comprehensive Assessments of Protein Structures[J]. Bioorg Med Chem,2012,20(12):3756-3767. | [11] | Morphy R. Selectively Nonselective Kinase Inhibition:Striking the Right Balance[J]. J Med Chem,2010,53(4):1413-1437. | [12] | GAO Hongliang,WANG Liuchang,LI Baolin. Syntheses of 4-Quinazoline Derivatives and Primary Study of Their Anti-Tumor Activity[J]. Chem Bull,2014,77(10):974-979(in Chinese). 高宏亮,王留昌,李宝林. 4-苯胺喹唑啉类化合物的合成与抗癌活性初步研究[J]. 化学通报,2014,77(10):974-979. | [13] | Tsuda Y,Hanajima M,Matsuhira N,et al.Regioselective Mono-Oxidation of Non-protected Carbohydrates by Brominolysis of the Tin Intermediates[J]. Chem Pharm Bull,1989,37(9):2344-2350. | [14] | Gong S W,He H F,Zhao C Q,et al.Convenient Deoxygenation of Aromatic Ketones by Silica-Supported Chitosan Schiff Base Palladium Catalyst[J]. Synth Commun,2012,42(4):574-581. | [15] | Zuidema D R,Williams S L,Wert K J,et al.Deoxygenation of Aromatic Ketones Using Transfer Hydrogenolysis with Raney Nickel in 2-Propanol[J]. Synth Commun,2011,41(19):2927-2931. | [16] | Zaccheria F,Ravasio N,Ercoli M,et al.Heterogeneous Cu-Catalysts for the Reductive Deoxygenation of Aromatic Ketones Without Additives[J]. Tetrahedron Lett,2005,46(45):7743-7745. | [17] | Deshpande P P,Ellsworth B A,Singh J. Methods of Producing C--Aryl Glucoside SGLT2 Inhibitors:US, 20040138439A1.[P],2004-07-15. | [18] | Yuyama Y,Sato T,Fujikawa S. A Palladium--Nanoparticle and Silicon-Nanowire-Array Hybrid:A Platform for Catalytic Heterogeneous Reactions[J]. Chem Med Chem,2014,9(5):962-972. | [19] | Chandregowda V,Rao G V,Kush A K,et al. A Process for the Synthesis of [6,7-Bis-(2-methoxyethoxy)-quinazolin-4-yl]-(3-ethynylphenyl)amine Hydrochloride:WO,2007138613.[P],2007-12-06. | [20] | SUN Jian,LI Jiaoyi,LI Baolin. Study on Synthetic Method of Antineoplastic Gefitinib[J]. Chem Res Appl,2013,25(8):1181-1184(in Chinese). 孙键,李娇毅,李宝林. 抗肿瘤药物吉非替尼的合成方法研究化学研究与应用[J]. 化学应用与研究,2013,25(8):1181-1184. |
|